XML 54 R35.htm IDEA: XBRL DOCUMENT v3.25.1

Equity (Tables)

12 Months Ended

Dec. 31, 2024

Offsetting Assets [Line Items]

Summary of Series F Activity

Since the Series F Closing Date, the Company has sold and issued Series F and Series F Warrants to Alpha or Investors that Alpha has assigned the Additional Investment Rights for cash proceeds through the exercise of their Series F Option. A summary of the Series F activity during the years ended December 31, 2024 and 2023 is as follows:

 Summary of Series F Activity

														Original								Shares Outstanding				Conversion Price				Shares Issuable
Date of Purchase		Shares Purchased				Gross Proceeds				Net Proceeds				Conversion Price				Series F Converted				December 31, 2024				December 31, 2024				December 31, 2024
March 9, 2023			3,000				3,000,000				3,000,000			$	420				(3,000	)			-				1.1000				-
November 15, 2023			1,850				1,850,000				1,850,000				124.70				(1,700	)			150				1.1000				136,364
December 31, 2023			4,850			$	4,850,000			$	4,850,000				-				(4,700	)			150				-				136,364
March 6, 2024			1,000				1,000,000				950,000			$	60.29				(565	)			435				1.1000				395,455
April 12, 2024			1,050				1,050,000				1,050,000				37.00				-				1,050				1.1000				954,545
May 31, 2024			1,050				1,050,000				1,025,000				32.15				-				1,050				1.1000				954,545
July 25, 2024			500				500,000				500,000				23.15				-				500				1.1000				454,545
August 27, 2024			500				500,000				500,000				20.19				-				500				1.1000				454,545
October 1, 2024 (i)			1,500				-				-				12.00				-				1,500				1.1000				1,363,636
December 18, 2024			750				750,000				750,000				5.25				-				750				5.2500				142,857
December 31, 2024			6,350			$	4,850,000			$	4,775,000				-				(565	)			5,785				-				4,720,128
Grand Total			11,200			$	9,700,000			$	9,625,000			$	-				(5,265	)			5,935				-				4,856,492

(i) These shares were issued as consideration for executing the Omnibus Agreement in connection with the October 2024 Offering.

Schedule of Significant Weighted Average Assumptions

For the years ended December 31, 2024 and 2023, the significant weighted average assumptions relating to the valuation of the Company’s stock options granted were as follows:

 Schedule of Significant Weighted Average Assumptions

		2024				2023
		Years Ended December 31,
		2024				2023
Stock price		$	—			$	0.32
Dividend yield			—	%			—	%
Expected life (years)			—				3.02
Expected volatility			—	%			63.64	%
Risk-free interest rate			—	%			4.22	%

Schedule of Deemed Dividends From various Down Round Triggers

Below is a summary of the deemed dividends resulting from various down round triggers that occurred during the year ended December 31, 2024:

 Schedule of Deemed Dividends From various Down Round Triggers

Deemed Dividends on Series F Preferred Stock
Date of		Description of		Series F				Conversion Prices				Conversion Price				Incremental Value
Trigger Event		Trigger Event		Outstanding				Prior to Trigger				After Trigger				Deemed Dividend
March 6, 2024		March 2024 Down Round Trigger			3,945			$	60.29 -124.50			$	30.00			$	5,102,674
August 27, 2024		August 2024 Down Round Trigger			3,755			$	23.15 - 37.00			$	20.19			$	1,233,685
October 1, 2024		October 2024 Offering			5,200			$	12.00 - 20.19			$	4.00			$	6,459,543
October 22, 2024		Share Combination Event			5,200			$	4.00			$	1.10			$	4,159,552
		Deemed Dividends on Series F														$	16,955,454

Deemed Dividends on Series F Warrants
Date of		Description of		Series F				Conversion Prices				Conversion Price				Incremental Value
Trigger Event		Trigger Event		Warrants Outstanding				Prior to Trigger				After Trigger				Deemed Dividend
March 6, 2024		March 2024 Down Round Trigger			54,695			$	60.29 - 124.50			$	30.00			$	147,030
August 27, 2024		August 2024 Down Round Trigger			137,331			$	23.15 - 37 .00			$	20.19			$	216,546
October 1, 2024		October 2024 Offering			162,096			$	20.19			$	4.00			$	365,665
October 22, 2024		Share Combination Event			162,096			$	4.00			$	1.10			$	64,007
		Deemed Dividends on Series F Warrants														$	793,248
		Warrant Modification (i)														$	7,752
		Total Deemed Dividends														$	17,756,454

(i) On May 31, 2024, the Company agreed to reduce the exercise price of a warrant held by Alpha originally issued in June 2023 from $380.00 to $30.00. As result, the Company recorded a deemed dividend of $7,752 for the incremental value due to the modification.

 

The below is a summary of the deemed dividends resulting from various down round triggers that occurred during the year ended December 31, 2023:

Deemed Dividends on Series F Preferred Stock
Date of		Description of						Conversion Prices				Conversion Price				Incremental Value
Trigger Event		Trigger Event		Series F Outstanding				Prior to Trigger				After Trigger				Deemed Dividend
March 9, 2023		March 2023 Down Round Trigger			5,159			$	440.00			$	420.00			$	217,750
June 6, 2023		June 2023 Down Round Trigger			7,025			$	420.00			$	250.00				3,867,095
November 15, 2023		November 2023 Down Round Trigger			6,075			$	250.00			$	100.00				5,832,000
		Deemed Dividends on Series F														$	9,916,845

Deemed Dividends on Series F Warrants
Date of		Description of		Series F				Conversion Prices				Conversion Price				Incremental Value
Trigger Event		Trigger Event		Warrants Outstanding				Prior to Trigger				After Trigger				Deemed Dividend
March 9, 2023		March 2023 Down Round Trigger			16,129			$	440.00			$	420.00			$	38,226
June 6, 2023		June 2023 Down Round Trigger			23,272			$	420.00			$	250.00				787,823
November 15, 2023		November 2023 Down Round Trigger			23,272			$	250.00			$	100.00				865,016
		Deemed Dividends on Series F Warrants														$	1,691,065
		Total Deemed Dividends														$	11,607,910

 

Summary of Restricted Stock Units Activity

For the year ended December 31, 2024, a summary of RSU activity is as follows:

 Summary of Restricted Stock Units Activity

		Shares				Weighted Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2023			3,054			$	910.29
Granted			7,959				16.54
Canceled			(3,020	)			25.16
Vested and released			(700	)			782.79
Outstanding as of December 31, 2024			7,293			$	324.64
Vested as of December 31, 2024			3,443			$	661.60
Unvested as of December 31, 2024			3,850			$	16.74

 

For the year ended December 31, 2023, a summary of RSU activity is as follows:

		Shares				Weighted Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2022			1,029			$	2,310
Granted			3,227				260
Canceled			(173	)			1,450
Vested and released			(1,029	)			210
Outstanding as of December 31, 2023			3,054			$	910.29
Vested as of December 31, 2023			2,861			$	930
Unvested as of December 31, 2023			193			$	490

 

Summary of Options Activity

For the year ended December 31, 2024, a summary of the options activity is as follows:

 Summary of Options Activity

		Shares				Weighted Average Exercise Price				Weighted Average Grant Date Fair Value				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2023			2,505			$	2,000			$	1,080				1.49			$	2,294
Granted			—				—				—				—				—
Exercised			—				—				—				—				—
Expired/forfeited			(2,449	)			1,953				1,060				—				—
Outstanding as of December 31, 2024			56			$	5,342			$	2,874				1.23			$	—
Exercisable as of December 31, 2024			56			$	5,342			$	2,874				1.23			$	—

For the year ended December 31, 2023, a summary of the options activity is as follows:

		Shares				Weighted Average Exercise Price				Weighted Average Grant Date Fair Value				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2022			2,561			$	2,180			$	1,190				3.33			$	31,124
Granted			325				320				150				3.02				—
Exercised			—				—				—				—				—
Expired/forfeited			(381	)			1,830				990				—				—
Outstanding as of December 31, 2023			2,505			$	2,000			$	1,080				1.49			$	2,294
Exercisable as of December 31, 2023			2,309			$	2,130			$	1,160				1.27			$	2,294

Equity Option [Member]

Offsetting Assets [Line Items]

Schedule of Significant Weighted Average Assumptions

During the years ended December 31, 2024 and 2023, we used the following assumptions in the Black-Scholes model used to compute the incremental value:

 Schedule of Assumptions in the Black-Scholes Model

		December 31, 2024				December 31, 2023
Expected term (years)			1 - 3				2 - 3
Volatility			84.88 - 152.24	%			89.35 - 149.26	%
Risk-free rate			3.52 - 4.55	%			4.10 - 4.90	%
Dividend yield			0.00	%			0.00	%

X

- Definition

Schedule Of Deemed Dividends From Various Down Round Triggers [Table Text Block]

+ References

No definition available.

+ Details

Name:	UAVS_ScheduleOfDeemedDividendsFromVariousDownRoundTriggersTableTextBlock
Namespace Prefix:	UAVS_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OffsettingAssetsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: